Medpace Holdings (MEDP) Return on Capital Employed (2016 - 2026)

Medpace Holdings (MEDP) has 11 years of Return on Capital Employed data on file, last reported at 88.67% in Q2 2026.

• Quarterly Return on Capital Employed fell 422.0% year-over-year to 88.67% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 88.67% (down 422.0% YoY) and the FY2025 annual result came in at 77.03%, up 1932.0% from the prior year.
• Return on Capital Employed rose to 88.67% in Q2 2026, from 79.56% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 133.99% in Q3 2025 to a low of 23.32% in Q1 2022.
• A 5-year average of 62.88% and a median of 52.07% in 2023 frame the typical range for Return on Capital Employed.
• Annual changes were most pronounced in 2024 — Return on Capital Employed plunged 1501 bps — and 2025, when it jumped 9143 bps.
• Tracing MEDP's Return on Capital Employed over 5 years: stood at 51.9% in 2022, then climbed by 0 bps to 52.09% in 2023, then decreased by 13 bps to 45.23% in 2024, then jumped by 127 bps to 102.77% in 2025, then decreased by 14 bps to 88.67% in 2026.
• The last three Return on Capital Employed figures came in at 88.67% (Q2 2026), 79.56% (Q1 2026), and 102.77% (Q4 2025), per Business Quant data.